Adtalem Global Education Inc. ATGE
We take great care to ensure that the data presented and summarized in this overview for Adtalem Global Education Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ATGE
View all-
Black Rock Inc. New York, NY5.97MShares$547 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$413 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.97MShares$272 Million0.06% of portfolio
-
Ariel Investments, LLC Chicago, IL2.25MShares$206 Million1.91% of portfolio
-
State Street Corp Boston, MA1.53MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.2MShares$110 Million0.22% of portfolio
-
Wellington Management Group LLP Boston, MA994KShares$91 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA966KShares$88.5 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA870KShares$79.7 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL870KShares$79.6 Million0.14% of portfolio
Latest Institutional Activity in ATGE
Top Purchases
Top Sells
About ATGE
Adtalem Global Education Inc. provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. The Walden segment offers online certificates, bachelor's, master's, and doctoral degrees, including nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. This segment also operates Walden University. The Medical and Veterinary segment provides degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.
Insider Transactions at ATGE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2024
|
William W Burke Director |
SELL
Open market or private sale
|
Direct |
4,000
-25.54%
|
$360,000
$90.39 P/Share
|
|
Nov 13
2024
|
Maurice Herrera SVP - Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+14.62%
|
$178,890
$89.85 P/Share
|
|
Nov 13
2024
|
Scott Liles President, Medical and Vet |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+27.86%
|
$266,110
$89.85 P/Share
|
|
Nov 13
2024
|
Robert J. Phelan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,220
+8.77%
|
$375,580
$89.85 P/Share
|
|
Nov 13
2024
|
Blake Simpson SVP, Chief Comms & CA Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+17.0%
|
$171,770
$89.85 P/Share
|
|
Nov 13
2024
|
Steven Tom SVP Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,850
+12.25%
|
$164,650
$89.85 P/Share
|
|
Nov 13
2024
|
Evan Trent President, Adtalem Elevate |
BUY
Grant, award, or other acquisition
|
Direct |
2,400
+14.24%
|
$213,600
$89.85 P/Share
|
|
Nov 13
2024
|
Beard, Stephen W. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,330
+15.5%
|
$5,547,370
$89.85 P/Share
|
|
Nov 13
2024
|
Michael Betz President, Walden University |
BUY
Grant, award, or other acquisition
|
Direct |
3,070
+13.09%
|
$273,230
$89.85 P/Share
|
|
Nov 13
2024
|
Karen Sue Cox President, Chamberlain Univ. |
BUY
Grant, award, or other acquisition
|
Direct |
2,110
+8.07%
|
$187,790
$89.85 P/Share
|
|
Nov 13
2024
|
Douglas G. Beck SVP, GC, Corp. Sec & ISS |
BUY
Grant, award, or other acquisition
|
Direct |
2,390
+5.55%
|
$212,710
$89.85 P/Share
|
|
Nov 13
2024
|
Manjunath Gangadharan VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
960
+14.46%
|
$85,440
$89.85 P/Share
|
|
Nov 13
2024
|
Lisa W Wardell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+1.46%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Michael W Malafronte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+1.49%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Sharon O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+9.33%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Kenneth J Phelan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+7.86%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Betty M. Vandenbosch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+50.0%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Donna J Hrinak Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+8.17%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
Georgette D. Kiser Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+8.66%
|
$138,840
$89.85 P/Share
|
|
Nov 13
2024
|
William V Krehbiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,560
+9.26%
|
$138,840
$89.85 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 175K shares |
|---|---|
| Exercise of conversion of derivative security | 249K shares |
| Payment of exercise price or tax liability | 111K shares |
|---|---|
| Open market or private sale | 335K shares |